Autoantibodies block IL-10 in 3.5% of IBD patients
The peer-reviewed work points to a distinct IBD subgroup and a possible blood-test route, but targeted treatment remains unproven.

Oxford, Newcastle and Cambridge University Hospitals researchers said Oct. 26 a New England Journal of Medicine study found IL-10-neutralizing antibodies in about 3.5% of more than 4,900 inflammatory bowel disease patients.
Inflammatory bowel disease, or IBD, includes Crohn's disease and ulcerative colitis and affects about 500,000 people in the UK and millions worldwide. The study suggests a biologically distinct subgroup, compared with healthy individuals in whom these antibodies were not detected.
Interleukin-10, or IL-10, is an immune-system signalling protein that helps restrain inflammation. The researchers said some patients produce antibodies that block IL-10, weakening a natural brake on inflammatory responses.
The antibodies were found in people with both Crohn's disease and ulcerative colitis. Based on UK IBD prevalence, the researchers estimated that 15,000 to 20,000 patients nationwide could carry the antibodies.
"We've suspected an important role of interleukin 10 in patients with inflammatory bowel disease for decades," said Holm Uhlig, senior author and director of the Centre for Human Genetics at the University of Oxford's Nuffield Department of Medicine. "The study now provides clear evidence and contributes the missing link between a well-known genetic variant that had been linked to severe inflammatory bowel disease in the past and the very recently discovered autoimmunity to interleukin 10."
The genetic link is HLA-DRB1*01:03, a variant Oxford scientists connected to severe IBD 30 years ago. The new study found a strong association between that variant and IL-10-blocking antibodies, offering a biological explanation for a long-observed risk factor.
The work also builds on research into rare inherited disorders involving IL-10 or its receptor. Sophie Hambleton, professor of pediatrics and immunology at Newcastle University, said earlier findings in young children helped researchers recognise that antibodies against IL-10 could mimic genetic defects in the same pathway.
The study cannot show that all IBD is driven by this mechanism. It also does not show that a blood test is ready for routine care, or that treatments aimed at the antibodies or the cells producing them improve outcomes. The source material did not provide age, sex or other demographic breakdowns for the study population.
For patients, the immediate implication is not a change in treatment but a clearer explanation for one subset of disease. The researchers said the findings could support development of a blood test to identify people whose IBD is linked to IL-10 antibodies and could guide future targeted-treatment studies.
Funding was provided through National Institute for Health and Care Research Biomedical Research Centres in Oxford, Cambridge and Newcastle.
Source: Peer-reviewed study, New England Journal of Medicine; University of Oxford release via ScienceDaily, Oct. 26, 2026.
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Three weekly wall-squat sessions cut systolic blood pressure 13.73 mmHg in small trial
- Jared Feather says knee fracture reshaped training for 18 months
Latest news
- Hull City 2–0 Brighton: When Resilience Beat Reputation
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike

